CHOP chemotherapy regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHOP chemotherapy regimen, covering 2025-04-13 to 2025-04-13. Get the full timeline:
Most recent: Clinical Trial Update: CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Group of CLL [Phase 2]